
Hope Elizabeth Uronis
Associate Professor of Medicine · Duke Department of Medicine
Credentials: ·
History
- Present
Duke Department of Medicine
- Present
Duke Cancer Institute
Research
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
New England Journal of Medicine · 2021 · 1,511 citations
Metastatic Pancreatic Cancer: ASCO Guideline Update
Journal of Clinical Oncology · 2020 · 249 citations
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2016 · 246 citations
- HH
22 papers

21 papers · 1 as a fellow

17 papers

17 papers

14 papers
- JB
10 papers · 1 as a fellow

10 papers
- AA
9 papers
Clinical trials
- 2018–2023
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
Principal investigator · Completed · Phase 2
Duke University
- 2007–2012
- 2007–2014
Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Principal investigator · Completed · Phase 2
Duke University
- 2023–2034
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group



